Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 9, 1997, Pages 2355-2362

  Kopp, Stephen J ^a,b   Daar, J ^a   Paulson, D J ^a   Romano, F D ^a   Laddaga, R ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

Diabetes mellitus

Indexed keywords

GLUCOSE TRANSPORTER; VANADYL SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE OXIDATION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0031238723     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0469     Document Type: Article

References (38)

1. BENDAYAN M, GINGRAS D, 1989. Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats. Diabetologia 32: 561-567.
2. BRICHARD SM, OKITOLONDA W, HENQUIN JC, 1988. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048-2053.
3. BRICHARD SM, ONGEMBA LN, KOLANOWSKI J, HENQUIN JC, 1991. The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats. J Endocrinol 131: 185-191.
4. BRICHARD SM, ASSIMACOPOULOS-JEANNET F, JEANRENAUD B, 1992. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology 131: 311-317.
5. BURCELIN R, PRINTZ RL, KANDE J, ASSAN R, GRANNER DK, GIRARD J, 1993. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am J Physiol Endocrinol Metab 265: E392-E401.
6. CAM MC, FAUN J, MCNEILL JH, 1995. Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats. Metabolism 44: 332-339.
7. 2 levels in rat skeletal muscle. Biochem Int 17: 359-366.
8. ECKEL J, REINAUER H, 1990. Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetes-induced alterations. Biochem Soc Trans 18: 1125-1127.
9. ERIKSSON JW, LONNROTH P, SMITH U, 1992. Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes. Diabetologia 35: 510-516.
10. FANTUS IG, AHMAD F, DERAGON G, 1990. Vanadate augments insulin binding and prolongs insulin action in rat adipocytes. Endocrinology 127: 2716-2725.
11. FOLEY JE, BELL PA, 1990. Molecular biology as a tool in the study of glucose transport and metabolism. Ann Med 22: 177-179.
12. FOOT E, BLISS T, FERNANDES LC, DA COSTA C, LEIGHTON B, 1992. The effects of orthovanadate, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparations in vitro. Mol Cell Biochem 109: 157-162.
13. GARVEY WT, HARDIN D, JUHASZOVA M, DOMINGUEZ JH, 1993. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 264: H837-H844.
14. HEI Y, CHEN X, PELECH SL, DIAMOND J, MCNEILL JH, 1995. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Diabetes 44: 1147-1155.
15. HEYLIGER CE, TAHILIANI AG, MCNEILL JH, 1985. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477.
16. KAINULAINEN H, BREINER M, SCHÜRMANN A, MARTTINEN A, VIRJO A, JOOST HG, 1994. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta Mol Basis Dis 1225: 275-282.
17. KANNEL WB, MCGEE DL, 1979. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 59: 8-13.
18. LAEMMLI UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
19. LEIGHTON B, COOPER GJS, DACOSTA C, FOOT EA, 1991. Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276: 289-292.
20. LINDGREN CA, PAULSON DJ, SHANAHAN MF, 1982. Isolated cardiac myocytes. A new cellular model for studying insulin modulation of monosaccharide transport. Biochim Biophys 721: 385-393.
21. MILDENBERGER RR, BAR-SHLOMO B, DRUCK MN, JABLONSKY G, MORCH JE, HILTON JD, KENSHOLE AB, FORBATH N, MCLAUGHLIN PR, 1984. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 4: 234-238.
22. MIRALPEIX M, GIL J, ROSA JL, CARRERAS J, BARTRONS R, 1989. Vanadate counteracts glucagon effects in isolated rat hepatocytes. Life Sci 44: 1491-1497.
23. MOUNTJOY KG, FLIER JS, 1990. Vanadate regulates glucose transporter (Glut-1) expression in NIH3T3 mouse fibroblasts. Endocrinology 126: 2778-2787.
24. OKUMURA N, SHIMAZU T, 1992. Vanadate stimulates D-glucose transport into sarcolemmal vesicles from rat skeletal muscles. J Biochem 112: 107-111.
25. OSBORN BA, DAAR JT, LADDAGA RA, ROMANO FD, PAULSON DJ, 1997. Exercise training increases sarcolemmal GLUT-4 and mRNA content in the diabetic rat heart. J Appl Physiol 82: 828-834.
26. PAQUET MR, ROMANEK RJ, SARGEANT RJ, 1992. Vanadate induces the recruitment of glut-4 glucose transporter to the plasma membrane of rat adipocytes. Mol Cell Biochem 109: 149-155.
27. PAULSON DJ, KOPP SJ, Tow JP, PEACE DG, 1986. Effects of vanadate on in vivo myocardial reactivity to norepinephrine. J Pharmacol Expt Ther 240: 529-534.
28. PEDERSON RA, RAMANADHAM S, BUCHAN MJ, MCNEILL JH, 1989. Long-term effects of vanadyl treatment on streptozotocin-induced diabetes in rats. Diabetes 38: 1390-1395.
29. + exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol 258: H255-H261.
30. PUGAZHENTHI S, KHANDELWAL RL, ANGEL JF, 1991. Insulin-like effect of vanadate on malic enzyme and glucose-6-phosphate dehydrogenase activities in streptozotocin-induced diabetic rat liver. Biochim Biophys Acta Lipids Lipid Metab 1083: 310-312.
31. RAMANADHAM S, BROWNEY R, CROS GH, MONGOLD JJ, MCNEILL JH, 1989. Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38: 1022-1028.
32. REGAN TJ, LYONS MM, AHMED SS, LEVINSON HA, OLDEWURTEL HA, AHMAD MR, HAIDER B, 1977. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885-899.
33. SAXENA AK, SRIVASTAVA P, BAQUER NZ, 1992. Effects of vanadate on glycolytic enzymes and malic enzyme in insulin-dependent and -independent tissues of diabetic rats. Eur J Pharmacol 216: 123-126.
34. SHECHTER Y, 1990. Insulin-mimetic effects of vanadate: possible implications for future treatment of diabetes. Diabetes 39: 1-5.
35. SHECHTER Y, SHISHEVA A, 1993. Vanadium salts and future treatment of diabetes. Endeavour 17: 27-31.
36. STROUT HV, VICARIO PP, BISWAS C, SAPERSTEIN R, BRADY EJ, PILCH PF, BERGER J, 1990. Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728-2732.
37. TAHILIANI AG, MCNEILL JH, 1986. Minireview: diabetes-induced abnormalities in the myocardium. Life Sciences 38: 959-974.
38. VERED Z, BATTLER A, SEGAL P, LIBERMAN D, YERUSHALMI Y BEREZIN M, NEUFELD HN, 1984. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 54: 633-637.